ZYDUSLIFE.NS Cash Flow
Zydus Lifesciences Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 7 years on file
(FY2019-20 to FY2025-26)
· fetched 2026-08-24 01:31
| Line item | FY2019-20 | FY2020-21 | FY2021-22 | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|---|---|---|
| Net Cash from Operating Activities | N/A | N/A | ₹20.78 Bn | ₹26.89 Bn | ₹32.28 Bn | ₹67.77 Bn | ₹21.17 Bn | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | N/A | N/A | ₹11.54 Bn | ₹11.71 Bn | ₹-14.75 Bn | ₹-83.72 Bn | ₹-82.96 Bn | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | N/A | N/A | ₹-8.68 Bn | ₹-44.00 Bn | ₹-18.04 Bn | ₹20.31 Bn | ₹59.97 Bn | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | N/A | N/A | ₹0.09 Bn | ₹0.07 Bn | ₹-0.23 Bn | ₹-0.21 Bn | ₹2.11 Bn | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | N/A | N/A | ₹23.73 Bn | ₹-5.34 Bn | ₹-0.75 Bn | ₹4.14 Bn | ₹0.28 Bn | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | N/A | N/A | ₹10.87 Bn | ₹11.07 Bn | ₹4.88 Bn | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from ZYDUSLIFE.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).